1.
|
Phase: Phase IV Type: Diagnostic, Treatment Status: Active Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: P0334, NCT01501487
|
|
2.
|
Phase: Phase III, Phase II Type: Biomarker/Laboratory analysis, Diagnostic, Treatment Status: Active Age: 19 and over Sponsor: NCI, Other Protocol IDs: 10-0366-04, NCI-2011-00710, NCT01391689
|
|
3.
|
Phase: Phase III Type: Treatment Status: Active Age: 40 and over Sponsor: Other Protocol IDs: 2009-APBI, WIRB #20091193, NCT01185132
|
|
4.
|
Phase: Phase II, Phase I Type: Treatment Status: Active Age: 41 and over Sponsor: Other Protocol IDs: 12-001 Single Fraction IORT, NCT01688388
|
|
5.
|
Phase: Phase II Type: Biomarker/Laboratory analysis, Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: NSABP FB-7, NCT01008150
|
|
6.
|
Phase: Phase II Type: Biomarker/Laboratory analysis, Treatment Status: Active Age: 18 and over Sponsor: NCI, Other Protocol IDs: CDR0000666991, RTOG-1014, NCT01082211
|
|
7.
|
Phase: Phase II Type: Biomarker/Laboratory analysis, Treatment Status: Active Age: 18 and over Sponsor: NCI, Other Protocol IDs: CDR0000675211, P30CA022453, WSU-2010-056, 2010-056, NCT01147016
|
|
8.
|
Phase: No phase specified Type: Biomarker/Laboratory analysis, Treatment Status: Active Age: 18 and over Sponsor: NCI, Other Protocol IDs: MCC-13311, NCI-2010-02342, P30CA016059, NCT01293032
|
|
9.
|
Phase: No phase specified Type: Natural history/Epidemiology, Treatment Status: Active Age: 50 and over Sponsor: NCI, Other Protocol IDs: ZCC-2010, U54CA142152-02, NCT01400399
|